CITY-FXI clinical trials

A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation

This study is testing a new medicine, CITY-FXI, for safety in healthy adults and those with specific blood clotting conditions. It's the first time this medicine is being given to people to see how their bodies react.